ducovest

BOUT:NYE-Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 36.3274

Change

-0.01 (-0.02)%

Market Cap

USD 0.01B

Volume

4.26K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

N/A

 USD 14.98B
VOT Vanguard Mid-Cap Growth Index ..

N/A

 USD 12.34B
IJK iShares S&P Mid-Cap 400 Growth..

N/A

 USD 9.44B
MDYG SPDR® S&P 400 Mid Cap Growth ..

N/A

 USD 2.87B
XMMO Invesco S&P MidCap Momentum ET..

N/A

 USD 2.14B
IVOG Vanguard S&P Mid-Cap 400 Growt..

N/A

 USD 0.95B
RFG Invesco S&P MidCap 400® Pure ..

N/A

 USD 0.33B
ETHO Etho Climate Leadership U.S. E..

N/A

 USD 0.18B
IPO Renaissance IPO ETF

N/A

 USD 0.17B
CWS AdvisorShares Focused Equity E..

N/A

 USD 0.14B

ETFs Containing BOUT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.83% 59% D- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.83% 59% D- 72% C
Trailing 12 Months  
Capital Gain 18.38% 18% F 67% D+
Dividend Return 1.42% 81% B- 19% F
Total Return 19.80% 18% F 63% D
Trailing 5 Years  
Capital Gain 80.24% 87% B+ 81% B-
Dividend Return 4.14% 53% F 14% F
Total Return 84.38% 87% B+ 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 14.63% 88% B+ 80% B-
Dividend Return 15.01% 88% B+ 78% C+
Total Return 0.38% 25% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 27.94% 38% F 40% F
Risk Adjusted Return 53.73% 75% C 81% B-
Market Capitalization 0.01B 6% D- 8% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.